Comparison |
| Container Type |
Single-Dose Tube | Single-Dose Tube | Prefilled Oral Applicator | Single-Dose Kit |
| Country of Origin |
United States | United States | Unknown | Unknown |
| Generic Drug Code |
26500 | 26500 | 24276 | 27017 |
| Generic Drug Name |
Rotavirus Vaccine, Live, Oral Pentavalent | Rotavirus Vaccine, Live, Oral Pentavalent | Rotavirus Vaccine, Live, Oral | Rotavirus Vaccine, Live Attenuated, 89-12, Preservative Free |
| NDC Number |
00006404720 | 00006404741 | 58160074021 | 58160085452 |
| Product Dating |
McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 180 days | |
| Strength |
| | 10E6 / mL | 10E6 / mL |
| User |
Indicated for People 6 to 32 Weeks of Age | Indicated for People 6 to 32 Weeks of Age | Indicated for People 6 to 24 Weeks of Age | Indicated for People 6 to 24 Weeks of Age |
| Volume |
2 mL | 2 mL | 1.5 mL | 1 mL |
| Application |
Rotavirus Vaccine | Rotavirus Vaccine | Rotavirus Vaccine | Rotavirus Vaccine |
| Dosage Form |
Solution | Solution | Solution | Solution |
| Storage Requirements |
Requires Refrigeration | Requires Refrigeration | Requires Refrigeration | Requires Refrigeration |
| Type |
Oral | Oral | Oral | Oral |
| UNSPSC Code |
51201618 | 51201618 | 51201618 | 51201618 |
| Features and Benefits |
- RotaTeq® is a vaccine indicated for the prevention of rotavirus gastroenteritis caused by types G1, G2, G3, G4, and G9
- RotaTeq is approved for use in infants 6 weeks to 32 weeks of age
- The vaccination series consists of three ready-to-use liquid doses of RotaTeq* administered orally starting at 6 to 12 weeks of age, with the subsequent doses administered at 4 to 10 week intervals
- Each dose is supplied in a container consisting of a squeezable plastic dosing tube with a twist-off cap, allowing for direct oral administration
- The dosing tube is contained in a pouch
- Package of 25 individually pouched single-dose tubes
|
- The vaccination series consists of three ready-to-use liquid doses of RotaTeq* administered orally starting at 6 to 12 weeks of age, with the subsequent doses administered at 4 to 10 week intervals
- 10 individually pouched single dose tubes
- Each dose is supplied in a container consisting of a squeezable plastic dosing tube with a twist-off cap, allowing for direct oral administration
|
|
- Administer first dose to infants beginning at 6 weeks of age
- Administer second dose after an interval of at least 4 weeks and prior to 24 weeks of age
- Vial of lyophilized vaccine to be reconstituted with accompanying liquid diluent in a prefilled oral applicator
- Includes a prefilled oral applicator of liquid diluent with a plunger stopper
- Includes a transfer adapter for reconstitution
- Store lyophilized vaccine refrigerated between 2 and 8 degrees C (36 and 46 degrees F)
- Diluent may be stored at controlled room temperature
|
